{"id":828,"date":"2026-10-20T03:13:25","date_gmt":"2026-10-20T01:13:25","guid":{"rendered":"http:\/\/novameds.local\/fr\/?post_type=product&#038;p=828"},"modified":"2026-10-20T04:00:04","modified_gmt":"2026-10-20T02:00:04","slug":"catalog-phenibut-hcl-powder-50-grams","status":"publish","type":"product","link":"https:\/\/novameds.health\/fr\/produit\/catalog-phenibut-hcl-powder-50-grams\/","title":{"rendered":"Phenibut HCL \u2013 Powder, 50 grams"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composition et d\u00e9tails du produit\">\n<h2>Composition et d\u00e9tails du produit<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Pr\u00e9sentation<\/h2>\n<div>\n<p><span>Phenibut HCL powder (50 g) provides a bulk format of \u03b2-phenyl-\u03b3-aminobutyric acid hydrochloride for research applications requiring solution preparation, dose titration, or formulation studies. The compound acts as a GABA-B agonist and GABA-A \u03c1 receptor modulator. The powder format enables flexible concentration preparation and is suited to pharmacokinetic studies, in vitro assays, and custom formulation research protocols.<\/span><\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11499499\" target=\"_blank\" rel=\"noopener noreferrer\">Donn\u00e9es mol\u00e9culaires sur PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Propri\u00e9t\u00e9s<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C10H14ClNO2<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>4-Amino-3-phenylbutanoic acid Phenibut 1078-21-3 Fenibut 4-Amino-3-phenylbutyric acid<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>215.67 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>3060-41-1<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>11499499<\/td>\n<\/tr>\n<tr>\n<th>Total Compound Content<\/th>\n<td>50 g powder<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Recherche<\/h2>\n<p>\t\t\t\t\t<span>Phenibut HCL powder provides the same compound as the capsule format in a bulk, unencapsulated form, enabling researchers to prepare solutions of defined concentration, perform weight-based dose titrations, or develop custom formulations. As a \u03b2-phenyl derivative of GABA, phenibut crosses the blood-brain barrier via passive diffusion (unlike GABA itself), acts as a GABA-B receptor agonist (lower potency than baclofen), and modulates GABA-A \u03c1 subunit-containing receptors. Plasma half-life is approximately 5 hours; minimal hepatic metabolism with ~90% urinary excretion unchanged. The 50 g format supports extended-duration studies, cohort-scale dosing, or in vitro concentration-response experiments requiring larger quantities than capsule-based formats allow. Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>R\u00e9sultats de laboratoire<\/h2>\n<p>Results refer to the tested sample. Check the batch and date in the report.<\/p>\n<div>\n<div>\n<div><\/div>\n<div>\n<div>Phenibut HCL (HPLC)<\/div>\n<div>January 21, 2026<\/div>\n<\/p><\/div>\n<div><a href=\"https:\/\/swisschems.is\/wp-content\/uploads\/2026\/06\/SC-HPLC-Phenibut-HCl-POWDER.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Open PDF<\/a><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What distinguishes the powder format from capsule formulations in research applications?<\/span><\/p>\n<\/summary>\n<div>\n<p>The powder format provides greater flexibility for analytical investigations, solution preparation, concentration standardization, and formulation development. Researchers can prepare solutions at precisely defined concentrations for biochemical assays, receptor-binding studies, and other laboratory applications.<\/p>\n<p>This versatility makes the powder format particularly useful for experimental designs requiring custom concentrations or multiple formulation conditions.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What are the solubility characteristics of Phenibut HCL powder?<\/span><\/p>\n<\/summary>\n<div>\n<p>Phenibut HCL is highly water-soluble due to its hydrochloride salt form and is also compatible with a variety of commonly utilized laboratory solvent systems. Its favorable solubility profile supports solution preparation, analytical characterization, formulation studies, and investigations of physicochemical properties.<\/p>\n<p>These characteristics make Phenibut HCL a convenient compound for research involving dissolved preparations and solution-based experimental systems.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How does Phenibut differ from baclofen in receptor pharmacology research?<\/span><\/p>\n<\/summary>\n<div>\n<p>Both Phenibut and baclofen are investigated for interactions with GABA-B receptors, but they exhibit distinct pharmacological and structural characteristics. Phenibut has also been reported to interact with GABA-A \u03c1 (rho) receptor systems, providing a broader receptor interaction profile than baclofen.<\/p>\n<p>These differences make Phenibut a useful research tool for comparative investigations of receptor selectivity, ligand-receptor interactions, GABAergic signaling mechanisms, and structure-activity relationships within GABA-related compounds.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Phenibut HCL powder (50 g) provides a bulk format of \u03b2-phenyl-\u03b3-aminobutyric acid hydrochloride for research applications requiring solution preparation, dose titration, or formulation studies.<\/p>\n<p>Conditionnement: Phenibut HCL \u2013 Powder, 50 grams.<\/p>\n<p class=\"nm-research-disclaimer\">R\u00e9serv\u00e9 \u00e0 la recherche en laboratoire. Ne pas utiliser chez l\u2019\u00eatre humain ou l\u2019animal.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Conditionnement illustratif g\u00e9n\u00e9r\u00e9 par IA.<\/small><\/p>\n","protected":false},"featured_media":1014,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[24],"product_tag":[],"nm_classification":[],"class_list":["post-828","product","type-product","status-publish","has-post-thumbnail","product_cat-cognitive-health-nootropics","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product\/828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/comments?post=828"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/media\/1014"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/media?parent=828"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_brand?post=828"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_cat?post=828"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/product_tag?post=828"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/fr\/wp-json\/wp\/v2\/nm_classification?post=828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}